132 related articles for article (PubMed ID: 17270405)
1. Phase transformations of erythromycin A dihydrate during pelletisation and drying.
Römer M; Heinämäki J; Miroshnyk I; Sandler N; Rantanen J; Yliruusi J
Eur J Pharm Biopharm; 2007 Aug; 67(1):246-52. PubMed ID: 17270405
[TBL] [Abstract][Full Text] [Related]
2. Phase transformation of erythromycin A dihydrate during fluid bed drying.
Römer M; Heinämäki J; Miroshnyk I; Kivikero N; Sandler N; Rantanen J; Yliruusi J
J Pharm Sci; 2008 Sep; 97(9):4020-9. PubMed ID: 18200525
[TBL] [Abstract][Full Text] [Related]
3. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of two drying methods on polymorphism of theophylline.
Airaksinen S; Karjalainen M; Räsänen E; Rantanen J; Yliruusi J
Int J Pharm; 2004 May; 276(1-2):129-41. PubMed ID: 15113621
[TBL] [Abstract][Full Text] [Related]
5. Stability of polymorphic forms of ranitidine hydrochloride.
Wu V; Rades T; Saville DJ
Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
[TBL] [Abstract][Full Text] [Related]
6. Role of an isomorphic desolvate in dissolution failures of an erythromycin tablet formulation.
Bauer JF; Dziki W; Quick JE
J Pharm Sci; 1999 Nov; 88(11):1222-7. PubMed ID: 10564073
[TBL] [Abstract][Full Text] [Related]
7. Stable sugar-based protein formulations by supercritical fluid drying.
Jovanović N; Bouchard A; Sutter M; Van Speybroeck M; Hofland GW; Witkamp GJ; Crommelin DJ; Jiskoot W
Int J Pharm; 2008 Jan; 346(1-2):102-8. PubMed ID: 17659851
[TBL] [Abstract][Full Text] [Related]
8. Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions.
Mirza S; Heinämäki J; Miroshnyk I; Rantanen J; Christiansen L; Karjalainen M; Yliruusi J
J Pharm Sci; 2006 Aug; 95(8):1723-32. PubMed ID: 16795009
[TBL] [Abstract][Full Text] [Related]
9. Effect of drying on extruded pellets based on kappa-carrageenan.
Thommes M; Blaschek W; Kleinebudde P
Eur J Pharm Sci; 2007 Jun; 31(2):112-8. PubMed ID: 17448646
[TBL] [Abstract][Full Text] [Related]
10. Supercritical fluid drying of carbohydrates: selection of suitable excipients and process conditions.
Bouchard A; Jovanović N; Hofland GW; Jiskoot W; Mendes E; Crommelin DJ; Witkamp GJ
Eur J Pharm Biopharm; 2008 Mar; 68(3):781-94. PubMed ID: 17702554
[TBL] [Abstract][Full Text] [Related]
11. Dehydration of trehalose dihydrate at low relative humidity and ambient temperature.
Jones MD; Hooton JC; Dawson ML; Ferrie AR; Price R
Int J Pharm; 2006 Apr; 313(1-2):87-98. PubMed ID: 16504430
[TBL] [Abstract][Full Text] [Related]
12. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
13. Pellet manufacturing by extrusion-spheronization using process analytical technology.
Sandler N; Rantanen J; Heinämäki J; Römer M; Marvola M; Yliruusi J
AAPS PharmSciTech; 2005 Sep; 6(2):E174-83. PubMed ID: 16353975
[TBL] [Abstract][Full Text] [Related]
14. The influence of lysozyme on mannitol polymorphism in freeze-dried and spray-dried formulations depends on the selection of the drying process.
Grohganz H; Lee YY; Rantanen J; Yang M
Int J Pharm; 2013 Apr; 447(1-2):224-30. PubMed ID: 23500620
[TBL] [Abstract][Full Text] [Related]
15. Implementation of a process analytical technology system in a freeze-drying process using Raman spectroscopy for in-line process monitoring.
De Beer TR; Allesø M; Goethals F; Coppens A; Heyden YV; De Diego HL; Rantanen J; Verpoort F; Vervaet C; Remon JP; Baeyens WR
Anal Chem; 2007 Nov; 79(21):7992-8003. PubMed ID: 17896825
[TBL] [Abstract][Full Text] [Related]
16. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
[TBL] [Abstract][Full Text] [Related]
17. Solid-state investigations of erythromycin A dihydrate: structure, NMR spectroscopy, and hygroscopicity.
Stephenson GA; Stowell JG; Toma PH; Pfeiffer RR; Byrn SR
J Pharm Sci; 1997 Nov; 86(11):1239-44. PubMed ID: 9383733
[TBL] [Abstract][Full Text] [Related]
18. Modeling and monitoring of polymorphic transformations during the drying phase of wet granulation.
Davis TD; Peck GE; Stowell JG; Morris KR; Byrn SR
Pharm Res; 2004 May; 21(5):860-6. PubMed ID: 15180346
[TBL] [Abstract][Full Text] [Related]
19. Real-time monitoring of changes of adsorbed and crystalline water contents in tablet formulation powder containing theophylline anhydrate at various temperatures during agitated granulation by near-infrared spectroscopy.
Otsuka M; Kanai Y; Hattori Y
J Pharm Sci; 2014 Sep; 103(9):2924-2936. PubMed ID: 24832393
[TBL] [Abstract][Full Text] [Related]
20. Immediate release of poorly soluble drugs from starch-based pellets prepared via extrusion/spheronisation.
Dukić-Ott A; Remon JP; Foreman P; Vervaet C
Eur J Pharm Biopharm; 2007 Nov; 67(3):715-24. PubMed ID: 17537625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
